SCHEMBL1034547

SCHEMBL1034547

COc1ccc(-c2ccnc(NC3CCCCC3)n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF2AK2 P19525 1/20 0.58
IKBKB O14920 3/20 0.54
PIK3CA P42336 3/20 0.53
PIK3CB P42338 3/20 0.53
PIK3CG P48736 3/20 0.53
CDK1 P06493 4/20 0.53
CCNB1 P14635 4/20 0.53
CDK4 P11802 3/20 0.53
CCNA2 P20248 3/20 0.53
CCND1 P24385 3/20 0.53
CDK2 P24941 3/20 0.53
CCNA1 P78396 3/20 0.53
CTSK P43235 1/20 0.52
CDK5 Q00535 1/20 0.52
CLK1 P49759 1/20 0.51
CLK2 P49760 1/20 0.51
DYRK1A Q13627 1/20 0.51
CLK4 Q9HAZ1 1/20 0.51
DYRK1B Q9Y463 1/20 0.51
MAPK10 P53779 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1033093 0.87 IKBKB (0.52) EIF2AK2IKBKBCDK1CCNB1CDK4
SCHEMBL1033097 0.85 MKNK1 (0.57) EIF2AK2PIK3CAPIK3CBPIK3CGCDK1
SCHEMBL1033843 0.85 HDAC8 (0.56) EIF2AK2IKBKBCDK1CCNB1CDK4
SCHEMBL5818203 0.84 EIF2AK2 (0.49) EIF2AK2IKBKBCDK1CCNB1CDK4
SCHEMBL5817943 0.83 EIF2AK2 (0.50) EIF2AK2IKBKBPIK3CAPIK3CBPIK3CG
SCHEMBL1034820 0.82 CDK4 (0.57) IKBKBCDK1CCNB1CDK4CCNA2
SCHEMBL1032138 0.82 IKBKB (0.76) EIF2AK2IKBKBPIK3CAPIK3CBPIK3CG
SCHEMBL1033987 0.82 IKBKB (0.56) IKBKBCDK1CCNB1CDK4CCNA2
SCHEMBL1029919 0.82 IKBKB (0.57) IKBKBCDK1CCNB1CDK4CCNA2
SCHEMBL1034404 0.82 CDK1 (0.51) EIF2AK2IKBKBCDK1CCNB1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed